Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer

Figure 1

Correlation between CYBRD1 expression and clinicopathological characteristics of patients with ovarian serous cystadenocarcinoma (OV) obtained from TCGA. FIGO stage (a), CR/PD-SD-PR (b), residual disease (c), venous invasion (d), lymphatic invasion (e), and anatomical site (f). TCGA: The Cancer Genome Atlas.

(a)

(b)

(c)

(d)

(e)

(f)